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Predictive clustering of POLG disease mutations into functional modules in the human mitochondrial replicase Laurie S. Kaguni We have established the genotype-phenotype correlations for the complete spectrum of POLG syndromes, by refining our previously described protocol for mapping pathogenic mutations in the human POLG gene to functional clusters in the catalytic core of the mitochondrial replicase, Pol γ. We assigned 136 mutations to five clusters and identify segments of primary sequence that can be used to delimit the boundaries of each cluster. We report that compound heterozygous patients with two mutations from different clusters manifested more severe, earlier onset POLG syndromes, whereas two mutations from the same cluster are less common and generally are associated with less severe, later onset POLG syndromes. We also show that specific cluster combinations are more severe than others, and have a higher likelihood to manifest at an earlier age. Our clustering method provides a powerful tool to predict the pathogenic potential and predicted disease phenotype of novel variants and mutations in POLG, the most common nuclear gene underlying mitochondrial disorders. We propose that such a prediction tool would be useful for routine diagnostics for mitochondrial disorders. Reactive oxygen species (ROS) are toxic to the cells and there must be specific defense mechanism in the cells to alleviate oxidative stress. The primarily responsible enzyme for this reaction is the Alkylhydroperoxide Reductase (AhpR) enzyme, consisting of the 57 kDa flavo protein AhpF (PrxR) expressed only by eubacteria and the 21 kDa AhpC (Prx) protein expressed in all kingdoms [1, 2] . The reduction of peroxides occurs via the redox active disulphide center of AhpC, whose reduced state becomes restored by AhpF, which transfers electrons from NADH onto AhpC. AhpF consists of three domains; thioredoxin (Trx) like N-terminal domain (NTD) attached to the thioredoxin reductase (TrxR) like Cterminal portion containing FAD-and NADH-binding domains. The proposed catalytic turnover of AhpF may require major domain motions, analogous to those deduced from bacterial Trx/TrxR system [3] . Here we are presenting for first time the crystal structure of E. coli AhpF complex with its substrate NADH at 2.5 Å resolution [4] . The structure reveals the basis of its substrate specificity for NADH over NADPH. In addition, it implies the alternating conformation required for the C-terminal NADH-binding domain to bring a bound NADH to the re-face of the isoalloxazine ring of flavin, and enabling the electron transfer to occur as well as the oxidation of NADH-domain dithiol via the redox active disulphide centre of the NTD. The detailed structural model will open future research opportunities to design selective drug against bacterial AhpF as potential target.
